During the last session, Cg Oncology Inc (NASDAQ:CGON)’s traded shares were 1.04 million, with the beta value of the company hitting 1.43. At the end of the trading day, the stock’s price was $26.83, reflecting an intraday gain of 8.19% or $2.03. The 52-week high for the CGON share is $46.99, that puts it down -75.14 from that peak though still a striking 10.88% gain since the share price plummeted to a 52-week low of $23.91. The company’s market capitalization is $2.04B, and the average trade volume was 711.67K shares over the past three months.
Cg Oncology Inc (CGON) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CGON has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.38.
Cg Oncology Inc (NASDAQ:CGON) trade information
Cg Oncology Inc (CGON) registered a 8.19% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.19% in intraday trading to $26.83, hitting a weekly high. The stock’s 5-day price performance is 6.94%, and it has moved by -8.62% in 30 days. Based on these gigs, the overall price performance for the year is -38.99%.
The consensus price target of analysts on Wall Street is $60, which implies an increase of 55.28% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $52 and $75 respectively. As a result, CGON is trading at a discount of -179.54% off the target high and -93.81% off the low.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 102.93k as predicted by 5 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 154.16k by the end of current fiscal year.
While earnings are projected to return -34.62% in 2025, the next five years will return 22.08% per annum.
CGON Dividends
Cg Oncology Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 3.67 million shares, is of TCG CROSSOVER MANAGEMENT, LLC’s that is approximately 5.5067% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $115.87 million.
Also, the Mutual Funds coming in first place with the largest holdings of Cg Oncology Inc (CGON) shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.73 shares. This amounts to just over 2.27 percent of the company’s overall shares, with a $46.3 million market value. The same data shows that the other fund manager holds slightly less at 1.35, or about 1.77% of the stock, which is worth about $36.09 million.
